Cristina Muntean, Bogdan Cătălin, Valerica Tudorică and Maria Moţa
, Toyooka K. Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy. J Neurol 255: 1693–1702, 2008.
32. Janghorbani M, Rezvanian H, Kachooei A et al. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Acta Neurol Scand 114: 384–391, 2006.
33. Mete T, Aydin Y, Saka M et al. Comparison of efficiencies of Michigan neuropathy screening instrument, neurothesiometer, and electromyography for diagnosis of diabetic neuropathy. Int J Endocrinol 2013: 821745, 2013
Smartphones and other mobile devices have become an integral component of daily life for many people worldwide, offering a broad and up-growing range of functions and utilities. Social media, the information and communication technology, and the enhanced usability and pervasiveness of mobile devices have resulted in an enormous interest in the development of a large diversity of health care applications. This dynamic time for new technologies that overlaps the current epidemic of diabetes and obesity gives smartphones the potential to play a role in increasing healthcare delivery and efficiency. Research has consistently shown that diabetes and obesity management represents the medical area where mobile devices could help in achieving therapeutic goals and enhance patients’ quality of life. This paper comprises a brief overview of the current state of development, requirements and regulations in the health mobile applications industry, and a short overlook on mobile applications diversity, safety and efficacy towards the self-management of individuals with diabetes mellitus and/ or obesity and the enhancement of their quality of life.
Alphonsus N. Onyiriuka, Abiola O. Oduwole, Elizabeth E. Oyenusi, Isaac O. Oluwayemi, Moustafa Kouyate, Olubunmi Fakaye, Chiedozie J. Achonwa and Mohammad Abdullahi
4. Cryer PE. Hypoglycaemia. In: Harrison’s Endocrinology, 2nd edition. Jameson JL (ed). McGraw Hill Companies, Inc, New York, pp. 314-322, 2010.
5. Ryan CM, Atchison J, Puczynski S, Puczynski M, Arslanian S, Becker D. Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. J Pediatr 117: 32-38, 1990.
6. Ryan C, Gurtunca N, Becker D. Hypoglycemia: a complication of diabetes therapy in children. Pediatr Clin North Am 52: 1705-1733, 2005
Raluca-Iulia Juncar, Mihai Juncar, Florin-Onişor Gligor and Amorin-Remus Popa
, Siéssere S et al. Bite force and masticatory efficiency in individuals with different oral rehabilitations Open Journal of Stomatology 2: 21-26, 2012.
8. Van der Bilt A, Tekamp A, Van der Glas H, Abbink J. Bite force and electromyography during maximum unilateral and bilateral clenching. Eur J Oral Sci 116: 217-222, 2008.
9. Bakke M. Mandibular elevator muscles: physiology, action, and effect of dental occlusion. Scand J Dent Res 101: 314-331, 1993.
10. Parle D, Desai D, Bansal A. Estimation of individual bite force during
Nasr-Eddine Kebir, Ahmed Aichouni and Touria Zahzeh
18: 499-502, 1972.
30. Manal MEM Shehata, Eman AM . Evaluation of therapeutic efficiency of camel milk on alloxan-induced diabetic rats. Journal of American Science 10: 53-60, 2014.
31. Agrawal RP, Saran S, Sharma P, Gupta RP, Kochar DK, Sahani MS . Effect of camel milk on residual β-cell function in recent onset type 1 diabetes. Diabetes Res Clin Pract 77: 494–495, 2007.
32. El-Agamy EI . Bioactive components in camel milk. In: Bioactive components in milk and dairy products. Park YW (Ed), Wiley-Blackwell, pp. 173, 2009.
33. Abd El